Do traditional VT zones improve outcome in primary prevention ICD patients?

Pacing Clin Electrophysiol. 2010 Nov;33(11):1353-8. doi: 10.1111/j.1540-8159.2010.02859.x. Epub 2010 Aug 18.

Abstract

Aims: We reviewed outcomes in our primary prevention implantable cardioverter defibrillator (ICD) population according to whether the device was programmed with a single ventricular fibrillation (VF) zone or with two zones including a ventricular tachycardia (VT) zone in addition to a VF zone.

Methods: This retrospective study examined 137 patients with primary prevention ICDs implanted at our institution between 2004 and 2006. Device programming and events during follow-up were reviewed. Outcomes included all-cause mortality, time to first shock, and incidence of shocks.

Results: Eighty-seven ICDs were programmed with a single VF zone (mean >193 ± 1 beats per minute [bpm]) comprising shocks only. Fifty ICDs had two zones (mean VT zone >171 ± 2 bpm; VF zone >205 ± 2 bpm), comprising antitachycardia pacing (100%), shocks (96%), and supraventricular (SVT) discriminators (98%) . Discriminator "time out" functions were disabled. Mean follow-up was 30 ± 0.5 months and similar in both groups. All-cause mortality (12.6% and 12.0%) and time to first shock were similar. However, the two-zone group received more shocks (32.0% vs 13.8% P = 0.01). Five of 16 shocks in these patients were inappropriate for SVT rhythms. The single-zone group had no inappropriate shocks for SVTs. Eighteen of 21 appropriate shocks were for ventricular arrhythmias at rates >200 bpm (three VF, 15 VT). This suggests that primary prevention ICD patients infrequently suffer ventricular arrhythmias at rates <200 bpm and that ATP may play a role in terminating rapid VTs.

Conclusions: Patients with two-zone devices received more shocks without any mortality benefit.

MeSH terms

  • Aged
  • Cardiomyopathies / complications
  • Cardiomyopathies / therapy
  • Defibrillators, Implantable*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Ischemia / therapy
  • Primary Prevention / instrumentation*
  • Retrospective Studies
  • Stroke Volume
  • Tachycardia, Supraventricular / diagnosis
  • Tachycardia, Supraventricular / mortality
  • Tachycardia, Supraventricular / prevention & control
  • Tachycardia, Supraventricular / therapy
  • Tachycardia, Ventricular / etiology
  • Tachycardia, Ventricular / mortality
  • Tachycardia, Ventricular / prevention & control*
  • Treatment Outcome
  • Ventricular Fibrillation / prevention & control
  • Ventricular Fibrillation / therapy